Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Cannabinoid CB2 receptors in human brain inflammation Benito C; Tolon RM; Pazos MR; Nunez E; Castillo AI; Romero JBr J Pharmacol 2008[Jan]; 153 (2): 277-85The presence of functional cannabinoid CB2 receptors in the CNS has provoked considerable controversy over the past few years. Formerly considered as an exclusively peripheral receptor, it is now accepted that it is also present in limited amounts and distinct locations in the brain of several animal species, including humans. Furthermore, the inducible nature of these receptors under neuroinflammatory conditions, in contrast to CB1, makes them attractive targets for the development of novel therapeutic approaches. In fact, the undesired psychoactive effects caused by CB1 activation have largely limited the clinical use of cannabinoid-related compounds that act on these receptors. In this review some recent findings on the antiinflammatory properties of CB2 receptors are presented, as well as new perspectives that have been obtained based on studies of human postmortem brain samples. In addition, various working hypotheses are also proposed and discussed.|AIDS Dementia Complex/pathology/physiopathology[MESH]|Alzheimer Disease/pathology/physiopathology[MESH]|Animals[MESH]|Anti-Inflammatory Agents/pharmacology/therapeutic use[MESH]|Encephalitis/pathology/*physiopathology[MESH]|Humans[MESH]|Inflammation/pathology/physiopathology[MESH]|Receptor, Cannabinoid, CB2/agonists/*physiology[MESH] |